Waldenstrom's Macroglobulinemia Recurrent
6 clinical trials · Condition
◉ Watch Waldenstrom's Macroglobulinemia Recurrent
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL (NCT05360238) | Mustang Bio | 2022-05-24 |
| Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product. (NCT05645744) | Mustang Bio | 2021-09-29 |
| Daratumumab Plus Ibrutinib in Patients With WaldenstrÓ§m's Macroglobulinemia (NCT03679624) | Weill Medical College of Cornell University | 2020-07-30 |
| A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia (NCT04440059) | Beijing InnoCare Pharma Tech Co., Ltd. | 2019-08-10 |
Track Waldenstrom's Macroglobulinemia Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.